Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: Efficacy and safety results of a randomised controlled phase III study

Nasonov, E., Fatenejad, S., Feist, E., Ivanova, M., Korneva, E., Krechikova, D. G., Maslyanskiy, A. L., Samsonov, M., Stoilov, R., Zonova, E. V. & Genovese, M., 3 Aug 2021, (E-pub ahead of print) In: Annals of the Rheumatic Diseases. 219876.

Research output: Contribution to journal › Article › peer-review

Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis

Novikova, N. S., Diatlova, A. S., Derevtsova, K. Z., Korneva, E. A., Fedotkina, T. V., Ostrinki, Y., Abraham, L., Quinn, S., Segal, Y., Churilov, L., Blank, M., Shoenfeld, Y., Aharoni, R. & Amital, H., 15 Dec 2019, In: Journal of Neuroimmunology. 337, p. 577070 8 p., 577070.

Research output: Contribution to journal › Article › peer-review

Corrigendum to “Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis” (Journal of Neuroimmunology (2019) 337, (S0165572819301687), (10.1016/j.jneuroim.2019.577070))

Novikova, N. S., Diatlova, A. S., Derevtsova, K. Z., Korneva, E. A., Abraham, L., Quinn, S., Segal, Y., Churilov, L. P., Fedotkina, T. V., Ostrinski, Y., Blank, M., Shoenfeld, Y., Aharoni, R. & Amital, H., Dec 2019, In: Journal of Neuroimmunology. 339, 2, 577137.

Research output: Contribution to journal › Comment/debate › peer-review